Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Payen

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Epidemiology and Infection|February 17, 2017
Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB StrategyM C Payen, J P VAN Vooren, O Vandenberg, et al.
Medecine Et Maladies Infectieuses|February 22, 2020
Tuberculosis and pseudoaneurysmsD De Smet, M C Payen, J Remes, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 14, 2012
Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosisM C Payen, S De Wit, C Martin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free casesM C Payen, I Muylle, O Vandenberg, et al.
Pulmonology|December 13, 2017
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyondL D'Ambrosio, G Bothamley, J A Caminero Luna, et al.
Pulmonology|March 23, 2021
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohortS Koirala, S Borisov, E Danila, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Epidemiology and Infection|February 17, 2017
Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB StrategyM C Payen, J P VAN Vooren, O Vandenberg, et al.
Medecine Et Maladies Infectieuses|February 22, 2020
Tuberculosis and pseudoaneurysmsD De Smet, M C Payen, J Remes, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 14, 2012
Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosisM C Payen, S De Wit, C Martin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free casesM C Payen, I Muylle, O Vandenberg, et al.
Pulmonology|December 13, 2017
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyondL D'Ambrosio, G Bothamley, J A Caminero Luna, et al.
Pulmonology|March 23, 2021
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohortS Koirala, S Borisov, E Danila, et al.
Pageof 2